Driving optichannel success through data-driven decision making
Marketing leaders from GSK, Novartis, Replimune, and PharmaForceIQ explore how optichannel strategy ensures meaningful, actionable information flows and unlocks measurable improvements in engagement, ROI, and outcomes.
Rare Revolution Insider: Moving beyond ‘spray and pray’ marketing
PharmaForceIQ is the industry’s first fully integrated optichannel platform, helping rare disease teams move beyond “spray and pray” to deliver personalized, real-time outreach and measurable results.
The optichannel data strategy that drove 69% sustained HCP engagement for a medical affairs team
Medical Affairs teams operate in a unique environment: high-value, unbranded scientific content to share, but strict compliance boundaries and lean budgets. Having just begun tiptoeing into more proactive outreach, medical affairs often relies on one or two channels like email or a single external partner. This leads to low engagement, wasted resources, and a frustrating […]
Optichannel bridges field coverage gaps: 41% increase in unique prescribers via digital only
Discover how PharmaForceIQ rapidly boosted patient engagement and website quality visits by 195% on a limited budget using a hyper-targeted, optichannel approach.
Pharmafile: Precision Engagement that Delivers Measurable ROI
This Q&A shares how data-driven insights and flexible channel selection empower organizations to maximize ROI, improve customer experience, and sustain value throughout the product lifecycle.
Pharmaceutical Commerce: Moving from Omnichannel to Optichannel Engagement Strategies
This Q&A explores why the industry needs to move away from persistently constrained omnichannel strategies and toward optichannel marketing approaches that boost personalization and ROI.
Real-time triggers unlock precision in rare disease marketing
Triggered media empowers marketers in niche indications to drive more personalized and meaningful engagement, building awareness over time and reaching HCPs when they have an eligible patient
The optichannel blueprint: How one brand engineered HCP engagement and rapid adoption at launch
Learn how Day One Biopharmaceuticals and PharmaForceIQ collaborated on a data-driven optichannel marketing campaign to drive success at launch in a complex indication.
Strategic advantage: Optichannel engagement drives ROI across the product lifecycle
This article in Pharmaceutical Executive explores how optichannel strategies bridge personal and nonpersonal efforts from early pre-launch planning through brand growth.
Webinar: From Omnichannel to Optichannel: Redefining Personalized Engagement in Life Sciences
Experts from Jazz Pharmaceuticals, Bristol Myers Squibb, and PharmaForceIQ discuss strategies to enhance personalization, improve resource allocation, harness AI, and drive measurable ROI.